PHAXIAM Therapeutics S.A. Overview
PHAXIAM Therapeutics S.A. Discounted Cash Flow
DCF Analysis for PHXM.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.89
Current Fair Value
$0.89
↓ 71.3% Downside
Overvalued by 71.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison